Advertisement

Topics

Bayer-Monsanto merger faces in-depth EU probe

03:51 EDT 23 Aug 2017 | Topix

Bayer AG and Monsanto Co. face an in-depth investigation by the European Union into their roughly $57 billion merger over concerns that it could lead to higher prices and fewer options for consumers in markets including pesticides and seeds, throwing into doubt the companies' plan to complete the tie-up by the end of the year.

Original Article: Bayer-Monsanto merger faces in-depth EU probe

NEXT ARTICLE

More From BioPortfolio on "Bayer-Monsanto merger faces in-depth EU probe"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...